UCB Transplant for Hematological DIseases Using a Non Myeloablative Prep
Conditions: Acute Leukemia; Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia/Lymphoma; Burkitt's Lymphoma; Natural Killer Cell Malignancies; Chronic Myelogenous Leukemia; Myelodysplastic Syndrome; Large-cell Lymphoma; Hodgkin Lymphoma; Multiple Myeloma; Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; Marginal Zone B-cell Lymphoma; Follicular Lymphoma; Lymphoplasmacytic Lymphoma; Mantle-cell Lymphoma; Prolymphocytic Leukemia; Bone Marrow Failure Syndromes; Myeloproliferative SyndromesInterventions: Drug: Fludarabine; Drug: Cyclophosphamide; Drug: MMF; Drug: Sirolimus; Radiation: TBI; Biological: Umbilical cord blood cell infusion; Biological: ATGSponsor: Masonic Cancer Center, University of MinnesotaNot yet recruiting - verified March 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bone Marrow Failure Syndrome (BMFS) | Burkitt Lymphoma | Cancer & Oncology | Hematology | Leukemia | Lymphoma | Myeloma | Research | Transplants